about
Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's diseaseSupracubital perineurioma misdiagnosed as carpal tunnel syndrome: case reportAge at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.NMDA receptor gene variations as modifiers in Huntington disease: a replication studyMusic perception and movement deterioration in Huntington's disease.Phonatory dysfunction as a preclinical symptom of Huntington disease.Striatal disorders dissociate mechanisms of enhanced and impaired response selection - Evidence from cognitive neurophysiology and computational modellingDose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data.No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.Error processing in Huntington's disease.Time processing in Huntington's disease: a group-control studyEfficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.Laquinimod treatment in the R6/2 mouse model.Hepatic mitochondrial dysfunction in Friedreich ataxia.No evidence of impaired gastric emptying in early Huntington's Disease.Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial.Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease.Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonographyAction selection in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary chorea.Oral and dental health in Huntington's disease - an observational studyPGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's diseaseAutonomic nervous system function in Huntington's disease.Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.Assessment of simple movements and progression of Huntington's disease.Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr?Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.The role of the immune system in Huntington's disease.Treating the whole body in Huntington's disease.Clinical utility gene card for: Huntington's disease.Prospective Evaluation of Predictive DNA Testing for Huntington's Disease in a Large German Center.Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.On the role of fronto-striatal neural synchronization processes for response inhibition--evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers."Theory of mind" is impaired in Huntington's disease.
P50
Q21261464-975ED766-FDCE-4040-8F1D-BAA38859D45CQ24801256-B41E4EF1-A459-4EFD-99C5-3978A8D038F0Q24810523-E3A87688-4DE5-4378-A8EB-5C7F862D44D3Q25257631-037664AA-55FA-4D32-B2FA-4764016E9B8AQ27499977-4E8C0F3B-ED64-446D-AA39-559DA7C958E4Q30407344-1E690A02-DDD6-4C71-B818-FB40356FFAA7Q30425545-C5E365EF-6D6B-4C82-956B-C69158F7B083Q30436674-44A87F15-D4E2-4EE7-B224-93091B1DE90FQ30477000-7F089CB5-3C2D-4C83-9D8D-8B619F15AC29Q30622209-3087C547-6CDF-4912-AEED-16629D46123FQ33263265-36B73DC3-8113-4E75-9727-DD12DF417F09Q33267342-F6FC510C-7178-4966-8A7B-813BAF2FC935Q33308722-4982DBF1-2FAE-412A-9A61-F525FEB91977Q33812932-65DC5DA3-A305-49AE-AA25-E53829707081Q33890346-9A53C55A-D7B8-48D2-B2BB-2726525EC319Q34075023-26246223-1326-4072-B34B-C85FD1862773Q34087126-CBF7C3C2-7D9C-44EB-9B9D-BF42528EB5D1Q34231219-2B369231-1266-4B67-8C98-94083674BCA0Q34581918-E2079FDC-289E-4FDF-B229-D4EA7F43FB07Q34828339-E09ADD4A-DE13-488B-A587-B810FD332684Q35019948-DC40A1ED-E7A9-43C9-A06F-A38C4A7302C3Q35020623-D3DB7744-4846-42FA-B5BB-C1446ACD9D26Q35052819-BAD6AE23-AF52-4D9F-9BE7-5331B2051F16Q35135962-0E99D430-A5FC-4639-8109-B4E6C8A8B026Q35262146-5FB44FE3-BDEA-43A2-8746-9B88AD4183C4Q35467961-8CC63F11-EE93-44B0-95D8-A537AAA8BCB2Q35478096-22C0133A-E4DF-4EF1-85B5-ACE683F9C8F0Q35479486-3496E0E6-53BD-4A20-B383-373B93AC69F6Q35684210-994E1B2D-7D60-434E-BA26-871EBB1DE61FQ36143277-92DB039F-00C1-4C2F-939B-99B83F55F496Q36316344-19B6002A-7DEA-4FC6-A076-176AB0112FAFQ36474714-62B6DDA0-23BC-4B81-A658-942E4FC0B1B7Q37284637-EAB585DF-BE03-450C-8527-A9788DF1095EQ38129870-3EC9A38E-9135-4C97-BF74-301CA501F1EBQ38607117-A9B543C8-3DD4-4351-B521-3959F013FBB6Q38839759-FC597D19-A1CA-4C90-B455-D8422E156C31Q38865495-83F9BA26-EF14-47AC-97A0-EEEE4B3F5C17Q39079841-38E85DFE-6515-42BD-9925-468FB5C61304Q39709057-169C4997-737D-4DF0-B4D5-C3C51FBC7BF6Q39774327-3624F90B-9775-46F2-BA8A-76481312CC39
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carsten Saft
@ast
Carsten Saft
@en
Carsten Saft
@es
Carsten Saft
@nl
Carsten Saft
@sl
type
label
Carsten Saft
@ast
Carsten Saft
@en
Carsten Saft
@es
Carsten Saft
@nl
Carsten Saft
@sl
prefLabel
Carsten Saft
@ast
Carsten Saft
@en
Carsten Saft
@es
Carsten Saft
@nl
Carsten Saft
@sl
P214
P106
P214
P31
P496
0000-0002-3983-7292
P734
P735
P7859
viaf-72129314